New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
New Delhi [India], July 4 (ANI): The Union Health Ministry on Friday has revised the dosage of the antiviral drug--remdesivir, being administered to hospitalized COVID-19 patients from the earlier six-days to five-day treatment course.